Literature DB >> 18398140

Hormone-sensitive lipase serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of beta-adrenergic stimulation.

Johan W E Jocken1, Carsten Roepstorff, Gijs H Goossens, Paula van der Baan, Marleen van Baak, Wim H M Saris, Bente Kiens, Ellen E Blaak.   

Abstract

OBJECTIVE: Increased intramuscular triacylglycerol (IMTG) storage is a characteristic of the obese insulin-resistant state. We aimed to investigate whether a blunted fasting or beta-adrenergically mediated lipolysis contributes to this increased IMTG storage in obesity. RESEARCH DESIGN AND METHODS: Forearm skeletal muscle lipolysis was investigated in 13 lean and 10 obese men using [(2)H(5)]glycerol combined with the measurement of arteriovenous differences before and during beta-adrenergic stimulation using the nonselective beta-agonist isoprenaline (ISO). Muscle biopsies were taken from the vastus lateralis muscle before and during ISO to investigate hormone-sensitive lipase (HSL) protein expression and serine phosphorylation.
RESULTS: Baseline total glycerol release across the forearm was significantly blunted in obese compared with lean subjects (P = 0.045). This was accompanied by lower HSL protein expression (P = 0.004), HSL phosphorylation on PKA sites Ser(563) (P = 0.041) and Ser(659) (P = 0.09), and HSL phosphorylation on the AMPK site Ser(565) (P = 0.007), suggesting a blunted skeletal muscle lipolysis in obesity. Total forearm glycerol uptake during baseline did not differ significantly between groups, whereas higher net fatty acid uptake across the forearm was observed in the obese (P = 0.064). ISO induced an increase in total glycerol release from skeletal muscle, which was not significantly different between groups. Interestingly, this was accompanied by an increase in HSL Ser(659) phosphorylation in obese subjects during ISO compared with baseline (P = 0.008).
CONCLUSIONS: Obesity is accompanied by impaired fasting glycerol release, lower HSL protein expression, and serine phosphorylation. It remains to be determined whether this is a primary factor or an adaptation to the obese insulin-resistant state.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398140      PMCID: PMC2453623          DOI: 10.2337/db07-0857

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  43 in total

1.  Marked heterogeneity of human skeletal muscle lipolysis at rest.

Authors:  Eva Hagström-Toft; Veronica Qvisth; Inger Nennesmo; Mikael Rydén; Helene Bolinder; Staffan Enoksson; Jan Bolinder; Peter Arner
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

2.  No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women.

Authors:  Erik Moberg; Stefan Sjöberg; Eva Hagström-Toft; Jan Bolinder
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-08       Impact factor: 4.310

3.  Effects of modulation of glycerol kinase expression on lipid and carbohydrate metabolism in human muscle cells.

Authors:  Eulàlia Montell; Carlos Lerín; Christopher B Newgard; Anna M Gómez-Foix
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

4.  Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity.

Authors:  Ranjana Sinha; Sylvie Dufour; Kitt Falk Petersen; Vincent LeBon; Staffan Enoksson; Yong-Zhan Ma; Mary Savoye; Douglas L Rothman; Gerald I Shulman; Sonia Caprio
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

5.  Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects.

Authors:  V Large; S Reynisdottir; D Langin; K Fredby; M Klannemark; C Holm; P Arner
Journal:  J Lipid Res       Date:  1999-11       Impact factor: 5.922

6.  Measurements of interstitial muscle glycerol in normal and insulin-resistant subjects.

Authors:  Mikaela Sjöstrand; Soffia Gudbjörnsdottir; Agneta Holmäng; Lena Strindberg; Karin Ekberg; Peter Lönnroth
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

7.  The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects.

Authors:  Ellen E Blaak; Anton J M Wagenmakers
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

8.  Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity observed before and after long-term weight reduction.

Authors:  Patrik Löfgren; Johan Hoffstedt; Mikael Rydén; Anders Thörne; Cecilia Holm; Hans Wahrenberg; Peter Arner
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

9.  Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recovery.

Authors:  G van Hall; M Sacchetti; G Rådegran; B Saltin
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

10.  Evidence for a substrate regulation of triglyceride lipolysis in human skeletal muscle.

Authors:  M Wicklmayr; G Dietze; K Rett; H Mehnert
Journal:  Horm Metab Res       Date:  1985-09       Impact factor: 2.936

View more
  12 in total

1.  High muscle lipid content in obesity is not due to enhanced activation of key triglyceride esterification enzymes or the suppression of lipolytic proteins.

Authors:  Minghua Li; Christopher Paran; Nathan E Wolins; Jeffrey F Horowitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-01       Impact factor: 4.310

2.  Glial cell line-derived neurotrophic factor protects against high-fat diet-induced obesity.

Authors:  Simon Musyoka Mwangi; Behtash Ghazi Nezami; Blessing Obukwelu; Mallappa Anitha; Smitha Marri; Ping Fu; Monica F Epperson; Ngoc-Anh Le; Malathy Shanmugam; Shanthi V Sitaraman; Yu-Hua Tseng; Frank A Anania; Shanthi Srinivasan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

3.  Beta2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men.

Authors:  Johan Onslev; Glenn Jacobson; Christian Narkowicz; Vibeke Backer; Anders Kalsen; Michael Kreiberg; Søren Jessen; Jens Bangsbo; Morten Hostrup
Journal:  Eur J Appl Physiol       Date:  2017-07-12       Impact factor: 3.078

4.  Insulin-mediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance.

Authors:  Johan W E Jocken; Gijs H Goossens; Hanneke Boon; Rachael R Mason; Yvonne Essers; Bas Havekes; Matthew J Watt; Luc J van Loon; Ellen E Blaak
Journal:  Diabetologia       Date:  2013-08-02       Impact factor: 10.122

5.  Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals.

Authors:  Cedric Moro; Jose E Galgani; LanChi Luu; Magdalena Pasarica; Aline Mairal; Sudip Bajpeyi; Gerd Schmitz; Dominique Langin; Gerhard Liebisch; Steven R Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-06-16       Impact factor: 5.958

Review 6.  AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.

Authors:  Rai Ajit K Srivastava; Stephen L Pinkosky; Sergey Filippov; Jeffrey C Hanselman; Clay T Cramer; Roger S Newton
Journal:  J Lipid Res       Date:  2012-07-13       Impact factor: 5.922

7.  The PRKAR1B p.R115K Variant is Associated with Lipoprotein Profile in African American Youth with Metabolic Challenges.

Authors:  Michelle Bloyd; Nikolaos Settas; Fabio Rueda Faucz; Ninet Sinaii; Kerstin Bathon; James Iben; Steven Coon; Sonia Caprio; Constantine A Stratakis; Edra London
Journal:  J Endocr Soc       Date:  2021-04-16

8.  Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans.

Authors:  Pierre-Marie Badin; Katie Louche; Aline Mairal; Gerhard Liebisch; Gerd Schmitz; Arild C Rustan; Steven R Smith; Dominique Langin; Cedric Moro
Journal:  Diabetes       Date:  2011-04-15       Impact factor: 9.461

9.  Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content.

Authors:  Paul M Coen; John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Robert E Ferrell; Frederico G S Toledo; Bret H Goodpaster
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

10.  The Pol-e-pill finally arrives.

Authors:  James A Levine; Ronald M Davis
Journal:  Diabetes       Date:  2008-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.